Inspired by patients. Driven by science.
For almost 80 years, we've been sharing our passion for innovation worldwide
- Today, UCB is a truly global company with operations in over 40 countries
- R&D facilities in the United States and Europe
- Over 9,000 employees
As leaders in the creation of biopharmaceutical solutions, the focus at UCB is on severe diseases treated by specialists in multiple therapeutic areas, including:
- Central nervous system
Specializing in immunological diseases
The expansion of our capabilities in antibody-based drug discovery has led us to new insights in the treatment of inflammatory autoimmune disorders.
At the heart of our mission is an ongoing commitment to empower specialists with highly innovative treatment options that improve patients' lives.